How much profit has Sundrug Co made this year?
Sundrug Co has made 29.13 B JPY this year.
Sundrug Co Net Income 2024
Sundrug Co Net Income
29.13 B JPY
Ticker
9989.T
ISIN
JP3336600006
WKN
895861
In 2024, Sundrug Co's profit amounted to 29.13 B JPY, a 13.32% increase from the 25.7 B JPY profit recorded in the previous year.
The Sundrug Co Net Income history
| YEAR | NET INCOME (undefined JPY) |
|---|---|
| 2027e | 35.91 |
| 2026e | 33.13 |
| 2025e | 30.8 |
| 2024 | 29.13 |
| 2023 | 25.7 |
| 2022 | 23.85 |
| 2021 | 25.33 |
| 2020 | 23.69 |
| 2019 | 23.93 |
| 2018 | 24.83 |
| 2017 | 23.31 |
| 2016 | 21.57 |
| 2015 | 16.36 |
| 2014 | 15.75 |
| 2013 | 14.96 |
| 2012 | 12.58 |
| 2011 | 10.87 |
| 2010 | 9.44 |
| 2009 | 8.92 |
| 2008 | 7.71 |
| 2007 | 7.49 |
| 2006 | 7.24 |
| 2005 | 6.52 |
Sundrug Co Revenue, EBIT, Net Income JP3336600006 · 895861
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Sundrug Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sundrug Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sundrug Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Sundrug Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Sundrug Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Sundrug Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sundrug Co’s growth potential.
Sundrug Co Revenue, EBIT and net profit per share
| Date | Sundrug Co Revenue | Sundrug Co EBIT | Sundrug Co Net Income |
|---|---|---|---|
| 2027e | 926.95 B undefined | 0 undefined | 35.91 B undefined |
| 2026e | 868.2 B undefined | 45.28 B undefined | 33.13 B undefined |
| 2025e | 812.55 B undefined | 43.47 B undefined | 30.8 B undefined |
| 2024 | 751.78 B undefined | 41 B undefined | 29.13 B undefined |
| 2023 | 690.46 B undefined | 37.45 B undefined | 25.7 B undefined |
| 2022 | 648.73 B undefined | 34.05 B undefined | 23.85 B undefined |
| 2021 | 634.31 B undefined | 37.35 B undefined | 25.33 B undefined |
| 2020 | 617.77 B undefined | 36.6 B undefined | 23.69 B undefined |
| 2019 | 588.07 B undefined | 35.23 B undefined | 23.93 B undefined |
| 2018 | 564.22 B undefined | 36.08 B undefined | 24.83 B undefined |
| 2017 | 528.39 B undefined | 34.06 B undefined | 23.31 B undefined |
| 2016 | 503.77 B undefined | 33.03 B undefined | 21.57 B undefined |
| 2015 | 445.82 B undefined | 25.92 B undefined | 16.36 B undefined |
| 2014 | 447.82 B undefined | 28.06 B undefined | 15.75 B undefined |
| 2013 | 407.4 B undefined | 24.72 B undefined | 14.96 B undefined |
| 2012 | 386.84 B undefined | 22.26 B undefined | 12.58 B undefined |
| 2011 | 360.66 B undefined | 19.24 B undefined | 10.87 B undefined |
| 2010 | 284.11 B undefined | 16.03 B undefined | 9.44 B undefined |
| 2009 | 232.53 B undefined | 14.76 B undefined | 8.92 B undefined |
| 2008 | 218.13 B undefined | 13.92 B undefined | 7.71 B undefined |
| 2007 | 197.77 B undefined | 12.69 B undefined | 7.49 B undefined |
| 2006 | 177.51 B undefined | 12.26 B undefined | 7.24 B undefined |
| 2005 | 153.95 B undefined | 11 B undefined | 6.52 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 153.95 B JPY | 11 B JPY | 6.52 B JPY |
| 2006 | 177.51 B JPY | 12.26 B JPY | 7.24 B JPY |
| 2007 | 197.77 B JPY | 12.69 B JPY | 7.49 B JPY |
| 2008 | 218.13 B JPY | 13.92 B JPY | 7.71 B JPY |
| 2009 | 232.53 B JPY | 14.76 B JPY | 8.92 B JPY |
| 2010 | 284.11 B JPY | 16.03 B JPY | 9.44 B JPY |
| 2011 | 360.66 B JPY | 19.24 B JPY | 10.87 B JPY |
| 2012 | 386.84 B JPY | 22.26 B JPY | 12.58 B JPY |
| 2013 | 407.4 B JPY | 24.72 B JPY | 14.96 B JPY |
| 2014 | 447.82 B JPY | 28.06 B JPY | 15.75 B JPY |
| 2015 | 445.82 B JPY | 25.92 B JPY | 16.36 B JPY |
| 2016 | 503.77 B JPY | 33.03 B JPY | 21.57 B JPY |
| 2017 | 528.39 B JPY | 34.06 B JPY | 23.31 B JPY |
| 2018 | 564.22 B JPY | 36.08 B JPY | 24.83 B JPY |
| 2019 | 588.07 B JPY | 35.23 B JPY | 23.93 B JPY |
| 2020 | 617.77 B JPY | 36.6 B JPY | 23.69 B JPY |
| 2021 | 634.31 B JPY | 37.35 B JPY | 25.33 B JPY |
| 2022 | 648.73 B JPY | 34.05 B JPY | 23.85 B JPY |
| 2023 | 690.46 B JPY | 37.45 B JPY | 25.7 B JPY |
| 2024 | 751.78 B JPY | 41 B JPY | 29.13 B JPY |
| 2025e | 812.55 B JPY | 43.47 B JPY | 30.8 B JPY |
| 2026e | 868.2 B JPY | 45.28 B JPY | 33.13 B JPY |
| 2027e | 926.95 B JPY | 0 JPY | 35.91 B JPY |
Sundrug Co stock margins JP3336600006 · 895861
The Sundrug Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sundrug Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sundrug Co.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Sundrug Co's sales revenue. A higher gross margin percentage indicates that the Sundrug Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Sundrug Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Sundrug Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sundrug Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sundrug Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sundrug Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Sundrug Co Margin History
| Sundrug Co Gross margin | Sundrug Co Profit margin | Sundrug Co EBIT margin | Sundrug Co Profit margin |
|---|---|---|---|
| 2027e | 25.18 % | 0 % | 3.87 % |
| 2026e | 25.18 % | 5.22 % | 3.82 % |
| 2025e | 25.18 % | 5.35 % | 3.79 % |
| 2024 | 25.18 % | 5.45 % | 3.87 % |
| 2023 | 24.9 % | 5.42 % | 3.72 % |
| 2022 | 24.12 % | 5.25 % | 3.68 % |
| 2021 | 25 % | 5.89 % | 3.99 % |
| 2020 | 25.03 % | 5.93 % | 3.84 % |
| 2019 | 25.03 % | 5.99 % | 4.07 % |
| 2018 | 24.98 % | 6.39 % | 4.4 % |
| 2017 | 24.74 % | 6.45 % | 4.41 % |
| 2016 | 24.64 % | 6.56 % | 4.28 % |
| 2015 | 24.28 % | 5.81 % | 3.67 % |
| 2014 | 23.64 % | 6.27 % | 3.52 % |
| 2013 | 23.69 % | 6.07 % | 3.67 % |
| 2012 | 23.24 % | 5.76 % | 3.25 % |
| 2011 | 22.68 % | 5.33 % | 3.01 % |
| 2010 | 23.16 % | 5.64 % | 3.32 % |
| 2009 | 23.52 % | 6.35 % | 3.84 % |
| 2008 | 23.04 % | 6.38 % | 3.53 % |
| 2007 | 22.99 % | 6.42 % | 3.79 % |
| 2006 | 22.35 % | 6.91 % | 4.08 % |
| 2005 | 21.99 % | 7.15 % | 4.23 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 21.99 % | 7.15 % | 4.23 % |
| 2006 | 22.35 % | 6.91 % | 4.08 % |
| 2007 | 22.99 % | 6.42 % | 3.79 % |
| 2008 | 23.04 % | 6.38 % | 3.53 % |
| 2009 | 23.52 % | 6.35 % | 3.84 % |
| 2010 | 23.16 % | 5.64 % | 3.32 % |
| 2011 | 22.68 % | 5.33 % | 3.01 % |
| 2012 | 23.24 % | 5.76 % | 3.25 % |
| 2013 | 23.69 % | 6.07 % | 3.67 % |
| 2014 | 23.64 % | 6.27 % | 3.52 % |
| 2015 | 24.28 % | 5.81 % | 3.67 % |
| 2016 | 24.64 % | 6.56 % | 4.28 % |
| 2017 | 24.74 % | 6.45 % | 4.41 % |
| 2018 | 24.98 % | 6.39 % | 4.4 % |
| 2019 | 25.03 % | 5.99 % | 4.07 % |
| 2020 | 25.03 % | 5.93 % | 3.84 % |
| 2021 | 25 % | 5.89 % | 3.99 % |
| 2022 | 24.12 % | 5.25 % | 3.68 % |
| 2023 | 24.9 % | 5.42 % | 3.72 % |
| 2024 | 25.18 % | 5.45 % | 3.87 % |
| 2025e | 25.18 % | 5.35 % | 3.79 % |
| 2026e | 25.18 % | 5.22 % | 3.82 % |
| 2027e | 25.18 % | 0 % | 3.87 % |
Sundrug Co Aktienanalyse
What does Sundrug Co do?
Sundrug Co Ltd is a Japanese company that was founded in Osaka in 1960. It started as a small pharmaceutical company that manufactured and sold over-the-counter medications and health products. Over the years, Sundrug has developed into a leading company in the Japanese health market. The business model of Sundrug is based on a comprehensive offering of health products and services. The company operates a variety of stores, including drugstores, pharmacies, supermarkets, and shopping centers, where it offers a wide range of products. The company is also involved in the manufacturing and marketing of pharmaceuticals and medical devices, and provides services such as health consultation and nursing care. One of the key divisions of Sundrug is its retail department, with its drugstores and pharmacies. Here, the company offers a wide range of over-the-counter medications, vitamins, and health products. The products range from cosmetic items to dietary supplements to enhance the well-being and health of customers. Another important division of Sundrug is the production of pharmaceutical products. The company manufactures a wide range of medications and medical devices, such as antibiotics, pain relievers, or diabetes medications. As part of its quality control, the company has a strict system for monitoring and testing its products. Sundrug is also active in the service industry and operates some hospitals and care facilities. The company offers consulting services and care services for elderly people. It operates as a non-profit organization and places great emphasis on promoting quality of life and health. The company also has a strong presence in the e-commerce sector. It operates an online platform where customers can conveniently order their health products from home. The company also offers a subscription service for regularly needed medications and products. Another important division of Sundrug is the cosmetic department. Here, the company offers a wide range of beauty products such as skin creams, shampoos, and makeup. The company follows the approach of meeting the needs of customers and offering products suitable for different age groups and skin types. Today, Sundrug is a leading company in the Japanese health market. Over the years, it has built a strong brand image and is known for its high-quality products and excellent services. The company places great emphasis on promoting health and well-being and strives to play a leading role in this market. Sundrug Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Sundrug Co's Profit Margins
The profit margins of Sundrug Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Sundrug Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Sundrug Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Sundrug Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Sundrug Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Sundrug Co stock
How has the profit developed compared to last year?
The profit has increased by 13.32% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Sundrug Co publish its earnings?
Sundrug Co publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Sundrug Co?
The profits of Sundrug Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Sundrug Co?
You can learn more about the earnings of Sundrug Co by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Sundrug Co pay?
Over the past 12 months, Sundrug Co paid a dividend of 122 JPY . This corresponds to a dividend yield of about 2.83 %. For the coming 12 months, Sundrug Co is expected to pay a dividend of 130.13 JPY.
What is the dividend yield of Sundrug Co?
The current dividend yield of Sundrug Co is 2.83 %.
When does Sundrug Co pay dividends?
Sundrug Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Sundrug Co?
Sundrug Co paid dividends every year for the past 23 years.
What is the dividend of Sundrug Co?
For the upcoming 12 months, dividends amounting to 130.13 JPY are expected. This corresponds to a dividend yield of 3.02 %.
In which sector is Sundrug Co located?
Sundrug Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Sundrug Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sundrug Co from 12/1/2024 amounting to 65 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Sundrug Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Sundrug Co in the year 2023?
In the year 2023, Sundrug Co distributed 107 JPY as dividends.
In which currency does Sundrug Co pay out the dividend?
The dividends of Sundrug Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sundrug Co
Our stock analysis for Sundrug Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sundrug Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
